Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA clearance on April 10 for adults with ...

Once-weekly basal insulin combined with an intermittently scanned continuous glucose monitor reduced HbA1c and improved time ...

Dexcom has been cash flow positive for since 2014 and more recently moved into positive earnings territory. While revenue has grown very quickly, research and development expenses and selling, general ...

San Diego-based Dexcom submitted its 15-day G7 CGM to the FDA in October 2024. The company says its 15-day G7 also meets ...

Dexcom stock surged Thursday after the Food and Drug Administration cleared its newest diabetes device for an extended 15-day ...

Market OverviewThe Global Smart Medical Devices Market is valued at USD 90.55 Billion in 2024 and is projected to reach a ...

There has been a major increase in health-conscious people seeking to use continuous glucose monitor (CGM ... that a CGM sold by Abbott (the Freestyle Libre 2) "systemically overestimated ...

For many of the almost 40 million people in the U.S. who live with diabetes, monitoring blood sugar levels multiple times a day can make the difference between good health and serious heart, kidney, ...